Retapamulin|cas 224452-66-8|supplier DC Chemicals

Cas No.:	224452-66-8
Chemical Name:	Acetic acid, 2-[[(3-exo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl]thio]-, (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester
SMILES:	O=C(CS[C@H]1C[C@@H]2CC[C@H](C1)N2C)O[C@@H]3C[C@@](C=C)([C@H]([C@@H](C4([C@@]5(C3(C)[C@@H](CC4)C)[H])CCC5=O)C)O)C
Formula:	C₃₀H₄₇NO₄S
M.Wt:	517.76
Purity:	99%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It is the first drug in the new class of pleuromutilin antibiotics to be approved For human use. It is marketed as an ointment under the brand names Altabax and Altargo. Retapamulin was approved by the United States Food and Drug Administration in April 2007 For the treatment of bacterial skin infections such as impetigo. In May 2007, retapamulin received approval in the EU from the European Medicines Agency For the same indication. For the detailed information about the solubility of Retapamulin in water, the solubility of Retapamulin in DMSO, the solubility of Retapamulin in PBS buffer, the animal experiment（test） of Retapamulin,the in vivo,in vitro and clinical trial test of Retapamulin,the cell experiment（test） of Retapamulin,the IC50, EC50 and Affinity of Retapamulin, please contact DC Chemicals.

MSDS

COA

LOT NO.	DOWNLOAD

2018-0101

Cat. No.	Product name	Field of application
DC8115	Vancomycin hydrochloride	Vancomycin hydrochloride in stock,price: 500 USD/100mg. 0
DC7940	TBA-354	TBA-354 is a potent anti-tuberculosis compound; maintains activity against Mycobacterium tuberculosis H37Rv isogenic monoresistant strains and clinical drug-sensitive and drug-resistant isolates.
DCAPI1325	Rifabutin (Mycobutin)	Rifabutin (Mycobutin)
DC4148	Retapamulin	Retapamulin is a topical antibiotic, which binds to both E. coli and S. aureus ribosomes with similar potencies with Kd of 3 nM.
DC4226	Moxifloxacin hydrochloride	Moxifloxacin(Avelox, Avalox) is a fourth generation synthetic fluoroquinolone antibacterial agent.
DC8893	Garenoxacin Mesylate hydrate	Garenoxacin mesylate hydrate is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity, against common respiratory pathogens, including resistant strains.
DC8929	Garenoxacin	Garenoxacin is a quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.
DC10307	Framycetin	Framycetin (Fradiomycin B; Neomycin B) is an aminoglycoside antibiotic. It inhibits hammerhead ribozyme with a Ki of 13.5 μM.
DC8937	Clarithromycin	Clarithromycin is a macrolide antibiotic and a CYP3A4 inhibitor.